| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 0 | 16.566 | 18.448 | 12.082 | 39.014 | 48.198 |
| Total Income - EUR | - | - | - | - | 888 | 25.986 | 21.292 | 14.936 | 41.859 | 51.026 |
| Total Expenses - EUR | - | - | - | - | 4.491 | 17.526 | 14.725 | 8.078 | 16.980 | 21.193 |
| Gross Profit/Loss - EUR | - | - | - | - | -3.603 | 8.460 | 6.567 | 6.858 | 24.879 | 29.834 |
| Net Profit/Loss - EUR | - | - | - | - | -3.603 | 8.480 | 6.383 | 6.739 | 24.497 | 28.605 |
| Employees | - | - | - | - | 1 | 2 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Dumpas Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 23.722 | 20.364 | 17.067 | 14.267 | 11.379 | 8.487 |
| Current Assets | - | - | - | - | 9.109 | 5.743 | 7.126 | 11.385 | 25.315 | 43.945 |
| Inventories | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | 7.788 | 382 | 3.628 | 4.511 | 8.660 | 5 |
| Cash | - | - | - | - | 1.321 | 5.361 | 3.499 | 6.874 | 16.655 | 43.940 |
| Shareholders Funds | - | - | - | - | -3.561 | 4.986 | 6.431 | 6.788 | 24.545 | 28.701 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 6.034 | 757 | 695 | 4.597 | 770 | 15.244 |
| Income in Advance | - | - | - | - | 30.359 | 20.364 | 17.067 | 14.267 | 11.379 | 8.487 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Dumpas Med S.r.l.